
### [NCIT:C45843](http://purl.obolibrary.org/obo/NCIT_C45843)
**Label:** Pancreatic Carcinoma with Mixed Differentiation

**Subclasses:** [NCIT:C6879](http://purl.obolibrary.org/obo/NCIT_C6879) (Mixed Ductal-Neuroendocrine Carcinoma of the Pancreas), [NCIT:C6878](http://purl.obolibrary.org/obo/NCIT_C6878) (Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas), [NCIT:C95460](http://purl.obolibrary.org/obo/NCIT_C95460) (Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas), 

**Class expressions from DL-Learner:**

- [UBERON:0001264](http://purl.obolibrary.org/obo/UBERON_0001264) (pancreas) 66.67%
- Thing 51.13%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) 41.05%
- [NCIT:C36753](http://purl.obolibrary.org/obo/NCIT_C36753) (Neoplastic Epithelial Cell) 39.63%
- [NCIT:C36745](http://purl.obolibrary.org/obo/NCIT_C36745) (Abnormal Epithelial Cell) 39.61%
- [UBERON:0002075](http://purl.obolibrary.org/obo/UBERON_0002075) (viscus) 39.03%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 36.84%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 36.68%
- [NCIT:C36825](http://purl.obolibrary.org/obo/NCIT_C36825) (Malignant Neuroendocrine Cell) 35.56%
- [NCIT:C36761](http://purl.obolibrary.org/obo/NCIT_C36761) (Neoplastic Neuroendocrine Cell) 31.74%
- [NCIT:C36929](http://purl.obolibrary.org/obo/NCIT_C36929) (Malignant Endocrine Cell) 28.14%
- [NCIT:C36925](http://purl.obolibrary.org/obo/NCIT_C36925) (Neoplastic Endocrine Cell) 24.89%
- [NCIT:C36773](http://purl.obolibrary.org/obo/NCIT_C36773) (Adenocarcinoma Cell) 24.89%
- [NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell) 24.78%
- [NCIT:C36764](http://purl.obolibrary.org/obo/NCIT_C36764) (Abnormal Glandular Cell) 23.07%


